Feasibility of corneal drug delivery of cysteamine using vitamin e modified silicone hydrogel contact lenses

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 85, Issue 3 PART A, 2013, Pages 531-540

  Hsu, Kuan Hui ^a   Fentzke, Richard C ^b   Chauhan, Anuj ^a  

^a University of Florida   (United States)

^b Ophthalmology: Riverside Cirby   (United States)

Author keywords

Contact lenses; Cysteamine; Cystinosis; Drug stability; Extended drug delivery; Vitamin E

Indexed keywords

ACUVUE; ALCOHOL; ALPHA TOCOPHEROL; EYE DROPS; MERCAPTAMINE; NARAFILCON; OASYS; PUREVISION; SILICONE; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; CONTACT LENS; CORNEA; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG OXIDATION; DRUG RELEASE; DRUG STABILITY; DRUG TRANSPORT; HYDROGEL; IN VITRO STUDY; TEAR FILM; THERAPY EFFECT; TREATMENT DURATION;

CONTACT LENSES; CYSTEAMINE; CYSTINOSIS; DRUG STABILITY; EXTENDED DRUG DELIVERY; VITAMIN E;

ADMINISTRATION, OPHTHALMIC; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CONTACT LENSES; CORNEA; CYSTEAMINE; DIFFUSION; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEASIBILITY STUDIES; HYDROGELS; MODELS, THEORETICAL; OPHTHALMIC SOLUTIONS; SILICONES; TIME FACTORS; VITAMIN E;

EID: 84888321700     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.04.017     Document Type: Article

References (41)

1. W.A. Gahl, N. Bashan, F. Tietze, I. Bernardini, and J.D. Schulman Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis Science 217 1982 1263 1265
2. W.A. Gahl, E.M. Kuehl, F. Iwata, A. Lindblad, and M.I. Kaiser-Kupfer Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops Mol. Genet. Metab. 71 2000 100 120
3. G. Nesterova, and W. Gahl Nephropathic cystinosis: late complications of a multisystemic disease Pediatr. Nephrol. 23 2008 863 878
4. E. Tsilou, M. Zhou, W. Gahl, P.C. Sieving, and C. Chan Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature Surv. Ophthalmol. 52 2007 97 105
5. R. Tavares, D. Coelho, M.C. Macario, A. Torres, M.J. Quadrado, and J. Murta Evaluation of treatment with cysteamine eyedrops for cystinosis with confocal microscopy Cornea 28 2009 938 940
6. J.L. Dufier, D. Orssaud, P. Dhermy, M.C. Gubler, M.F. Gagnadoux, C. Kleinknecht, and M. Broyer Ocular changes in some progressive hereditary nephropathies Pediatr. Nephrol. 1 1987 525 530
7. J.G. Thoene, R.G. Oshima, J.C. Crawhall, D.L. Olson, and J.A. Schneider Cystinosis - intracellular cystine depletion by aminothiols in vitro and in vivo J. Clin. Invest. 58 1976 180 189
8. V.E. Kimonis, J. Troendle, S.R. Rose, M.L. Yang, T.C. Markello, and W.A. Gahl Effects of early cysteamine therapy on thyroid-function and growth in nephropathic cystinosis J. Clin. Endocr. Metab. 80 1995 3257 3261
9. W.A. Gahl, F. Tietze, J.D. Butler, and J.D. Schulman Cysteamine depletes cystinotic leukocyte granular fractions of cystine by the mechanism of disulfide interchange Biochem. J. 228 1985 545 550
10. F. Iwata, E.M. Kuehl, G.F. Reed, L.M. McCain, W.A. Gahl, and M.I. Kaiser-Kupfer A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis Mol. Genet. Metab. 64 1998 237 242
11. A. Cantani, O. Giardini, and A.C. Cantani Nephropathic cystinosis - ineffectiveness of cysteamine therapy for ocular changes Am. J. Ophthalmol. 95 1983 713 714
12. N.P. Jones, R.J. Postlethwaite, and J.L. Noble Clearance of corneal crystals in nephropathic cystinosis by topical cysteamine 0.5-percent Br. J. Ophthalmol. 75 1991 311 312
13. J.L. Simpson, C.J. Nien, K.J. Flynn, and J.V. Jester Evaluation of topical cysteamine therapy in the CTNS-/- knockout mouse using in vivo confocal microscopy Mol. Vis. 17 2011 2649 2654
14. E.T. Tsilou, D. Thompson, A.S. Lindblad, G.F. Reed, B. Rubin, W. Gahl, J. Thoene, M. Del Monte, J.A. Schneider, D.B. Granet, and M.I. Kaiser-Kupfer A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis Br. J. Ophthalmol. 87 2003 28 31
15. J.E. Biaglow, R.W. Issels, L.E. Gerweck, M.E. Varnes, B. Jacobson, J.B. Mitchell, and A. Russo Factors influencing the oxidation of cysteamine and other thiols - implications for hyperthermic sensitization and radiation protection Radiat. Res. 100 1984 298 312
16. B.E. Svensson, and S. Lindvall Myeloperoxidase oxidase oxidation of cysteamine Biochem. J. 249 1988 521 530
17. D.S. Friedman, B. Nordstrom, E. Mozaffari, and H.A. Quigley Glaucoma management among individuals enrolled in a single comprehensive insurance plan Ophthalmology 112 2005 1500 1504
18. C.L. Bourlais, L. Acar, H. Zia, P.A. Sado, T. Needham, and R. Leverge Ophthalmic drug delivery systems - recent advances Prog. Retin. Eye Res. 17 1998 33 58
19. I.M. MacDonald, L.P. Noel, G. Mintsioulis, and W.N. Clarke The effect of topical cysteamine drops on reducing crystal formation within the cornea of patients affected by nephropathic cystinosis J. Pediatr. Ophthalmol. Strabismus 27 1990 272 274
20. M.I. Kaiserkupfer, L. Fujikawa, T. Kuwabara, S. Jain, and W.A. Gahl Removal of corneal crystals by topical cysteamine in nephropathic cystinosis N. Engl. J. Med. 316 1987 775 779
21. M.I. Kaiserkupfer, M.A. Gazzo, M.B. Datiles, R.C. Caruso, E.M. Kuehl, and W.A. Gahl A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis Arch. Ophthalmol. 108 1990 689 693
22. J.A. Bradbury A randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosis Eye (London) 5 1991 755 760
23. J.L. Creech, A. Chauhan, and C.J. Radke Dispersive mixing in the posterior tear film under a soft contact lens Ind. Eng. Chem. Res. 40 2001 3015 3026
24. C.C. Li, and A. Chauhan Modeling ophthalmic drug delivery by soaked contact lenses Ind. Eng. Chem. Res. 45 2006 3718 3734
25. P.S. Soni, D.G. Horner, L. Jimenez, J. Ross, and J. Rounds Will young children comply and follow instructions to successfully wear soft contact lenses? CLAO J. 21 1995 86 92
26. J.J. Walline, S. Long, and K. Zadnik Daily disposable contact lens wear in myopic children Optometry Vision Sci. 81 2004 255 259
27. P. Cho, S.W. Cheung, and M. Edwards The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control Curr. Eye Res. 30 2005 71 80
28. J.J. Walline, L.A. Jones, M.J. Rah, R.E. Manny, D.A. Berntsen, M. Chitkara, A. Gaume, A. Kim, and N. Quinn Clip Study Grp, Contact Lenses in Pediatrics (CLIP) study: chair time and ocular health Optometry Vision Sci. 84 2007 896 902
29. C.C.S. Karlgard, N.S. Wong, L.W. Jones, and C. Moresoli In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials Int. J. Pharm. 257 2003 141 151
30. C.-C. Peng, J. Kim, and A. Chauhan Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing Vitamin E diffusion barriers Biomaterials 31 2010 4032 4047
31. C.-C. Peng, and A. Chauhan Extended cyclosporine delivery by silicone-hydrogel contact lenses J. Control. Release 154 2011 267 274
32. C.-C. Peng, M.T. Burke, and A. Chauhan Transport of topical anesthetics in vitamin E loaded silicone hydrogel contact lenses Langmuir 28 2012 1478 1487
33. C.-C. Peng, A. Ben-Shlomo, E.O. Mackay, C.E. Plummer, and A. Chauhan Drug delivery by contact lens in spontaneously glaucomatous dogs Curr. Eye Res. 37 2012 204 211
34. C.-C. Peng, M.T. Burke, B.E. Carbia, C. Plummer, and A. Chauhan Extended drug delivery by contact lenses for glaucoma therapy J. Control. Release 162 2012 152 158
35. J. Kim, and A. Chauhan Dexamethasone transport and ocular delivery from poly(hydroxyethyl methacrylate) gels Int. J. Pharm. 353 2008 205 222
36. J. Kim, A. Conway, and A. Chauhan Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses Biomaterials 29 2008 2259 2269
37. C.-C. Peng, and A. Chauhan Ion transport in silicone hydrogel contact lenses J. Membr. Sci. 399 2012 95 105
38. M.R. Prausnitz, and J.S. Noonan Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye J. Pharm. Sci. 87 1998 1479 1488
39. S. Jain, T. Kuwabara, W.A. Gahl, and M.I. Kaiserkupfer Range of toxicity of topical cysteamine in rabbit eyes J. Ocul. Pharmacol. 4 1988 127 131
40. H. Zhu, and A. Chauhan A mathematical model for ocular tear and solute balance Curr. Eye Res. 30 2005 841 854
41. H. Zhu, and A. Chauhan A mathematical model for tear drainage through the canaliculi Curr. Eye Res. 30 2005 621 630